Clinical trial
Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria in Hospitalised Patients (SATURN 04)
NCT01208519 is registered in ClinicalTrials.gov with Catholic University of the Sacred Heart as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria in Hospitalised Patients (SATURN 04)
- Lead sponsor
- Catholic University of the Sacred Heart
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2010
- Completion date
- January 31, 2015
- Enrollment
- 16,680 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
bacterial resistance, infection due to esbl bacteria, infection resistant to multiple drugs, staph aureus methicillin resistant colonization